1. 1. Meiying Song#, Qianlong Meng#, Xuan Jiang, Meizhu Xiao, Jun liu, Zhenyu zhang, Jing wang*, Huimin Bai*..Phospholipase D1 promotes cervical cancer progression by activating the RAS pathway..Journal of Cellular and Molecular Medicine.2022.26(15).4244-4253.SCI |
2. Chang Hui#, Huimin Bai#*, Jun Liu, Xuerong Lu, Shuzhen Wang, Zhenyu Zhang, Mulan Jin, Yue Wang , and Yuzhen Liu*.Accuracy of HPV E6/E7 RNA examination using in situ hybridization in diagnosing cervical intraepithelial lesions.Diagnostic pathology.2021.16(1).13.SCI |
3. Ruili Jiao#,Shipeng Sun#,Xiaoqiong Gao,Ran Cui,Guangming Cao,Huali Wei,Shuzhen Wang,Zhenyu Zhang*,Huimin Bai*.A Polyethylene Glycol-Based Method for Enrichment of Extracellular Vesicles from Culture Supernatant of Human Ovarian Cancer Cell Line A2780 and Body Fluids of High-Grade Serous Carcinoma Patients.Cancer Management and Research.2020.12.6291-6301.SCI |
4. Tong Lou#,Yutao Gao#,Ying Feng,Junli Lu,Zhenyu Zhang*,and Huimin Bai*.Reproductive outcomes of cesarean scar pregnancy pretreated with methotrexate and uterine artery embolization prior to curettage.Taiwanese journal of obstetrics & gynecology. .2020.59(3).381-386.SCI |
5. Cheng Liu#,Ran Cui,Miaomiao Li,Ying Feng,Huimin Bai*,and Zhenyu Zhang*.The Safety and Efficacy of Intra-Arterial versus Intravenous Neoadjuvant Chemotherapy in Patients with Locally Advanced Cervical Cancer: A Meta-Analysis.Evid Based Complement Alternat Med.2020.2020.5023405.SCI |
6. Ran Cui#,GuangMing Cao,Huimin Bai*,and Zhenyu Zhang* .LPAR1 regulates the development of intratumoral heterogeneity in ovarian serous cystadenocarcinoma by activating the PI3K/AKT signaling pathway.Cancer Cell Int.2019.19.201.SCI |
7. 鲁梦寒 白会敏* 王淑珍*.早产风险孕产妇产前使用硫酸镁安全且能降低新生儿脑瘫风险.英国医学杂志中文版.2019. .666-668.EI |
8. Xuan Jiang#,Xiaoying Li,Weihua Li,Huimin Bai*,and Zhenyu Zhang*.Current status and future prospects of PARP inhibitor clinical trials in ovarian cancer.Cancer management and research.2019.11.4371-4390.SCI |
9. Guyu Zhang#,Yimin Zhu,Yushu Wang,Dengshuai Wei,Yixin Wu,Liucun Zheng,Huimin Bai*,Haihua Xiao*,Zhenyu Zhang*.pH/redox sensitive nanoparticles with platinum(IV) prodrugs and doxorubicin enhance chemotherapy in ovarian cancer.RSC Advances.2019.2019(9).20513-20517.SCI |
10. Ying Feng#,Zihan Zhang,Tong Lou,Shuzhen Wang,Huimin Bai*,and Zhenyu Zhang*.The security of radical trachelectomy in the treatment of IA-IIA cervical carcinoma requires further evaluation: updated meta-analysis and trial sequential analysis.Archives of Gynecology and Obstetrics.2019.299(6).1525-1536.SCI |
11. Cui Rui#,Cao Guangming,Huimin Bai*,and Zhenyu Zhang*.The clinical benefits of hormonal treatment for LG-ESS: a meta-analysis.Archives of gynecology and obstetrics.2019.300(5).1167-1175.SCI |
12. Miaomiao Li#,Tao Guo,Ran Cui,Ying Feng,Huimin Bai*,and Zhenyu Zhang*.Weight control is vital for patients with early-stage endometrial cancer or complex atypical hyperplasia who have received progestin therapy to spare fertility: a systematic review and meta-analysis.Cancer management and research.2019.11.4005-4021.SCI |
13. Xuan Jiang#,Xiaoying Li,Weihua Li,Huimin Bai*,and Zhenyu Zhang*.PARP inhibitors in ovarian cancer: Sensitivity prediction and resistance mechanisms.Journal of Cellular and Molecular Medicine.2019.23(4).2303-2313.SCI |
14. Ying Feng#,Zihan Zhang,Tong Lou,Shuzhen Wang,Huimin Bai*,and Zhenyu Zhang*.The safety of fertility preservation for microinvasive cervical adenocarcinoma: a meta-analysis and trial sequential analysis .Archives of gynecology and obstetrics.2018.298(3).465-475.SCI |
15. Huimin Bai#,Jun Liu#,Qiuxi Wang,Feng Ying,Tong Lou,Shuzhen Wang,Yue Wang,Mulan Jin,and Zhenyu Zhang*.Oncological and reproductive outcomes of adenocarcinoma in situ of the cervix managed with the loop electrosurgical excision procedure.BMC Cancer.2018.18(1).461.SCI |
16. Ran Cui#,Menghui Li,Junli Lu,Huimin Bai*,and Zhenyu Zhang* .Management strategies for patients with placenta accreta spectrum disorders who underwent pregnancy termination in the second trimester: a retrospective study.BMC pregnancy and childbirth.2018.18(1).298.SCI |
17. 白会敏 李海霞 李民华 刘军 龚丽云 张震宇*.如何利用现有的临床病例资源撰写高影响因子论文.首都医科大学学报.2018.4(1).71-75.核心期刊 |
18. Tong Lou#,Fang Yuan,Ying Feng,Shuzhen Wang,Huimin Bai*,and Zhenyu Zhang*.The safety of fertility and ipsilateral ovary procedures for borderline ovarian tumors.Oncotarget.2017.8(70).115718-115729.SCI |
19. Ran Cui#,Junli Lu,Zhenyu Zhang*,and Huimin Bai*.The feasibilty of conservative management for morbidly adherent placenta accidently encounted after vaginal delivery.Gynecologic and Obstetric Investigation.2017.82(5).494-499.SCI |
20. Ran Cui#,Fang Yuan,Junli Lu,Zhenyu Zhang*,and Huimin Bai*.Clinicopathological characteristics for low grade endometrial stromal sarcoma patients and treatment strategies for patients with relapse or distant metastasis.Medicine (Baltimore).2017.96(15).e6684.SCI |
21. 白会敏 刘军 龚丽云 王淑珍 张震宇*.医学研究生Sci论文写作一些技巧和建议.继续医学教育杂志.2017.31(9).113-116.核心期刊 |
22. Huimin Bai#,Dongyan Cao#,Fang Yuan,Guisha Sha,Jiaxin Yang,Jie Chen,Yue Wang,Zhenyu Zhang*,and Keng Shen*.Prognostic value of endometriosis in patients with stage I ovarian clear cell carcinoma: Experiences at three academic institutions.Gynecol Oncol.2016.143(3).526-531.SCI |
23. Huimin Bai#,Dongyan Cao#,Jiaxin Yang,Menghui Li,Zhenyu Zhang*,and Keng Shen*.Genetic and epigenetic heterogeneity of epithelial ovarian cancer and the clinical implications for molecular targeted therapy.Journal of Cellular and Molecular Medicine.2016.20.581-593.SCI |
24. Huimin Bai#, Dongyan Cao#, Fang Yuan, Huilan Wang, Menghui Li, Jie Chen, Quancai Cui, Zhenyu Zhang*, and Keng Shen*. Accuracy of conization procedure for predicting pathological parameters of radical hysterectomy in stage Ia2-Ib1 (<=2 cm=""> |
25. Huimin Bai#,Dongyan Cao#,Fang Yuan,Huilan Wang,Jie Chen,Yue Wang,Keng Shen*,and Zhenyu Zhang*.Occult invasive cervical cancer found after simple hysterectomy: A multi-center retrospective study with 89 cases.BMC cancer.2016.16(1).507.SCI |
26. Huimin Bai#,Guisha Sha,Meizhu Xiao,Huiqiao Gao,Dongyan Cao,Jiaxin Yang,Jie Chen,Yue Wang,Zhenyu Zhang*,and Keng Shen*. The prognostic value of pretreatment CA-125 levels and CA-125 normalization in ovarian clear cell carcinoma: a two-academic-institute study.Oncotarget.2016.6.15566-15576.SCI |
27. Huimin Bai#,Fang Yuan, Huilan Wang,Jie Chen,Quancai Cui,and Keng Shen*.The potential for less radical surgery in women with stage IA2-IB1 cervical cancer.International Journal of Gynecology & Obstetrics.2015.130(3).235-240 .SCI |
28. Huimin Bai#,Haixia Li#,Weihua Li,Ting Gui,Jiaxin Yang,Dongyan Cao*,and Keng Shen*.The PI3K/AKT/mTOR pathway is a potential predictor of distinct invasive and migratory capacities in human ovarian cancer cell lines.Oncotarget.2015.6.25520-25532.SCI |
29. Huimin Bai#,Guihua Sha#,Dongyan Cao,Jiaxin Yang,Jie Chen,Yue Wang,Jinghe Lang,Keng Shen*,and Zhenyu Zhang*.Salvage Chemotherapy for Patients With Recurrent or Persistent Ovarian Clear Cell Carcinoma:A Retrospective Study of 164 Cases.Medicine (Baltimore).2015.94(27).e1121.SCI |
30. Ting Gui#,Huimin Bai#,Jianfang Zeng,Zhaoji Zhong,Dongyan Cao,Quancai Cui,Jie Chen,Jiaxin Yang,and Keng Shen*.Tumor heterogeneity in the recurrence of epithelial ovarian cancer demonstrated by Polycomb group proteins.OncoTargets and Therapy.2014.7.1705-1716.SCI |
31. Huimin Bai# and Keng Shen*.Reply letter to “Primary surgical treatment of pelvic aggressive angiomyxoma is not always advisable in ER positive patients”.Eur J Surg Oncol.2014.40(5).594-595.SCI |
32. Huimin Bai,Jiaxin Yang,Dongyan Cao,Huifang Huang,Yang Xiang,Ming Wu,Qauncai Cui,Jie Chen,Jinghe Lang,and Keng Shen*.Ovary and uterus-sparing procedures for low-grade endometrial stromal sarcoma: a retrospective study of 153 cases.Gynecologic oncology.2014.132(3).654-660.SCI |
33. Huimin Bai#,Jiaxin Yang,Huifang Huang,Dongyan Cao,Jie Chen,Ning Yang,Jinghe Lang,and Keng Shen*.Individualized managing strategies of aggressive angiomyxoma of female genital tract and pelvis.Eur J Surg Onc.2013.39(10).1101-1108.SCI |
34. 白会敏 杜彦芳 王惠兰*.胎盘植入的诊断与治疗.中国妇产科临床杂志.2011.12.318-320.核心期刊 |
35. 白会敏 王惠兰*.胎盘植人晚期产后出血.中国实用妇科与产科杂志.2011.27.227-230.核心期刊 |
36. 白会敏 钱素敏 贾利刚 王惠兰*.雌、孕激素对子宫内膜癌细胞株Ishikawa体外生长的影响.中国实用妇科与产科杂志.2010.26.440-442.核心期刊 |
37. 白会敏 徐静 王惠兰* 杜彦芳.bFGF、MVD、PCNA在子宫肌瘤组织中的表达及其相关性研究.河北医科大学学报.2010.4.403-405.核心期刊 |
38. 白会敏 王惠兰* 陈素琴 尹桂然.转化生长因子-β1、β3及其受体βRI、βRII mRNA及蛋白在子宫肌瘤组织中的表达.河北医科大学学报.2003.3.155-156.核心期刊 |